What's Happening?
The national cancer plan for England, published in February 2026, sets ambitious targets to improve cancer outcomes by 2035. The plan aims for 75% of people diagnosed with cancer to be cancer-free or living well five years later, potentially saving 320,000
lives. Key priorities include prevention, early diagnosis, person-centered care, and world-leading research. The plan also addresses health inequalities that lead to later diagnosis and poorer outcomes among socioeconomically disadvantaged groups. The British Oncology Pharmacy Association (BOPA) and pharmacy workforce are recognized for their role in patient care, with initiatives like delivering chemotherapy at home and supporting early diagnosis in community pharmacies.
Why It's Important?
The cancer plan's focus on prevention and early diagnosis is crucial for improving survival rates and reducing healthcare disparities. By involving pharmacy professionals, the plan leverages their trusted relationships with the public to raise awareness and encourage participation in screening programs. This approach can help address barriers such as cultural beliefs and mistrust of healthcare, ultimately leading to earlier diagnosis and better outcomes. The plan's emphasis on inclusive research and innovation aims to ensure that new treatments are accessible to all, preventing the widening of health inequalities.
Beyond the Headlines
Pharmacy professionals play a vital role in reducing inequalities across the cancer continuum. Their accessibility and trust within communities make them key players in addressing health literacy and cultural barriers. In secondary care, pharmacists ensure medicines optimization and provide culturally competent advice, supporting adherence and confidence in care. The plan also highlights the importance of inclusive research practices, advocating for better data granularity and equitable recruitment. By embedding equity assessments in service design and research, pharmacy professionals can champion inclusion and ensure that cancer care is equitable and accessible to all.
